Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Perspectives] Thalidomide and journalism’s golden era

The thalidomide disaster was such a desperate tragedy that it is hard to imagine newspapers of the time were not running daily, probing front-page stories, pointing the finger of blame and demanding justice for the victims and their families. Yet they were not. Distillers, the company that marketed the drug which caused birth defects, was sheltered by a judicial system in the UK that prevented public exposure of what went wrong while compensation claims were being heard in the courts.